|
Alzheimer Disease
Citations 21-30 of 46 total displayed.
|
Past content
(since Mar 1998):
|
- Original Articles
Assessment of Capacity to Consent to Research Among Older Persons With Schizophrenia, Alzheimer Disease, or Diabetes Mellitus: Comparison of a 3-Item Questionnaire With a Comprehensive Standardized Capacity Instrument
- Barton W. Palmer; Laura B. Dunn; Paul S. Appelbaum; Sunder Mudaliar; Leon Thal; Robert Henry; Shahrokh Golshan; Dilip V. Jeste
Arch Gen Psychiatry 2005; 62: 726-733.
[Abstract]
[Full text]
[PDF]
- Original Articles
Sex Differences in the Clinical Manifestations of Alzheimer Disease Pathology
- Lisa L. Barnes; Robert S. Wilson; Julia L. Bienias; Julie A. Schneider; Denis A. Evans; David A. Bennett
Arch Gen Psychiatry 2005; 62: 685-691.
[Abstract]
[Full text]
[PDF]
- Original Articles
Variability of Familial Risk of Alzheimer Disease Across the Late Life Span
- Jeremy M. Silverman; Gregory Ciresi; Christopher J. Smith; Deborah B. Marin; Michal Schnaider-Beeri
Arch Gen Psychiatry 2005; 62: 565-573.
[Abstract]
[Full text]
[PDF]
- Original Articles
Apolipoprotein E  4 Allele and Lorazepam Effects on Memory in High-Functioning Older Adults
- Nunzio Pomara; Lisa Willoughby; Keith Wesnes; David J. Greenblatt; John J. Sidtis
Arch Gen Psychiatry 2005; 62: 209-216.
[Abstract]
[Full text]
[PDF]
- Original Articles
Do Statins Reduce Risk of Incident Dementia and Alzheimer Disease?: The Cache County Study
- Peter P. Zandi; D. Larry Sparks; Ara S. Khachaturian; JoAnn Tschanz; Maria Norton; Martin Steinberg; Kathleen A. Welsh-Bohmer; John C. S. Breitner; for the Cache County Study Investigators
Arch Gen Psychiatry 2005; 62: 217-224.
[Abstract]
[Full text]
[PDF]
- Original Articles
Apolipoprotein E  4 Count Affects Age at Onset of Alzheimer Disease, but Not Lifetime Susceptibility: The Cache County Study
- Ara S. Khachaturian; Christopher D. Corcoran; Lawrence S. Mayer; Peter P. Zandi; John C. S. Breitner
Arch Gen Psychiatry 2004; 61: 518-524.
[Abstract]
[Full text]
[PDF]
- Original Articles
Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosis of Alzheimer Disease: A Comparative Cerebrospinal Fluid Study
- Harald Hampel; Katharina Buerger; Raymond Zinkowski; Stefan J. Teipel; Alexander Goernitz; Niels Andreasen; Magnus Sjoegren; John DeBernardis; Daniel Kerkman; Koichi Ishiguro; Hideto Ohno; Eugeen Vanmechelen; Hugo Vanderstichele; Cheryl McCulloch; Hans-Jürgen Möller; Peter Davies; Kaj Blennow
Arch Gen Psychiatry 2004; 61: 95-102.
[Abstract]
[Full text]
[PDF]
- Original Articles
Treating Depression in Alzheimer Disease: Efficacy and Safety of Sertraline Therapy, and the Benefits of Depression Reduction: The DIADS
- Constantine G. Lyketsos; Lourdes DelCampo; Martin Steinberg; Quincy Miles; Cynthia D. Steele; Cynthia Munro; Alva S. Baker; Jeannie-Marie E. Sheppard; Constantine Frangakis; Jason Brandt; Peter V. Rabins
Arch Gen Psychiatry 2003; 60: 737-746.
[Abstract]
[Full text]
[PDF]
- Original Articles
Familial Patterns of Risk in Very Late-Onset Alzheimer Disease
- Jeremy M. Silverman; Christopher J. Smith; Deborah B. Marin; Richard C. Mohs; Cathi B. Propper
Arch Gen Psychiatry 2003; 60: 190-197.
[Abstract]
[Full text]
[PDF]
- Original Articles
Early and Widespread Cholinergic Losses Differentiate Dementia With Lewy Bodies From Alzheimer Disease
- Pietro Tiraboschi; Larry A. Hansen; Michael Alford; Annette Merdes; Eliezer Masliah; Leon J. Thal; Jody Corey-Bloom
Arch Gen Psychiatry 2002; 59: 946-951.
[Abstract]
[Full text]
[PDF]
|
|
